NOBELA Trademark

Trademark Overview

On Thursday, February 23, 2012, a trademark application was filed for NOBELA with the United States Patent and Trademark Office. The USPTO has given the NOBELA trademark a serial number of 85550532. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 7, 2015. This trademark is owned by Glaxo Group Limited. The NOBELA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
nobela

General Information

Serial Number85550532
Word MarkNOBELA
Filing DateThursday, February 23, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 7, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 12, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
Translation of Words in MarkThe English translation of "NOBELA" in the mark is "NOVEL".

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 1, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Tuesday, September 8, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 7, 2015ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 21, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 20, 2015EXTENSION 5 GRANTED
Thursday, January 15, 2015EXTENSION 5 FILED
Thursday, January 15, 2015TEAS EXTENSION RECEIVED
Saturday, July 19, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 18, 2014EXTENSION 4 GRANTED
Monday, July 14, 2014EXTENSION 4 FILED
Monday, July 14, 2014TEAS EXTENSION RECEIVED
Friday, February 7, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 6, 2014EXTENSION 3 GRANTED
Monday, January 27, 2014EXTENSION 3 FILED
Monday, January 27, 2014TEAS EXTENSION RECEIVED
Saturday, August 31, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 30, 2013EXTENSION 2 GRANTED
Tuesday, July 30, 2013EXTENSION 2 FILED
Friday, August 30, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 30, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 8, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 7, 2013EXTENSION 1 GRANTED
Friday, January 25, 2013EXTENSION 1 FILED
Thursday, February 7, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 25, 2013TEAS EXTENSION RECEIVED
Tuesday, August 7, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 12, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 12, 2012PUBLISHED FOR OPPOSITION
Wednesday, May 23, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 7, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, May 3, 2012ASSIGNED TO LIE
Monday, April 16, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 13, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 13, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 13, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 10, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 10, 2012NON-FINAL ACTION E-MAILED
Tuesday, April 10, 2012NON-FINAL ACTION WRITTEN
Tuesday, April 10, 2012ASSIGNED TO EXAMINER
Thursday, March 1, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, February 27, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

nobela pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic